Surgeons in operating rooms are set to get augmented reality holograms. Surgeon Dr. David Pearlstone is harbouring plans to introduce three-dimensional imaging for his compatriots. Pearlstone, the CEO of Dicom Director, a branch of Ted Dinsmore owned SphereGen, has been a full-time surgeon and liver oncology specialist throughout his career. He had estimated that every hospital would adopt augmented reality (AR) systems in the near future.
Pearlstone said that those who are aware of interventional medicine processes would welcome the ability to view things in three dimensions. He believes it can help surgeons approach medical issues differently. According to Pearlstone, an MRI or CT scan can be utilised in several ways in a hologram form. Pearlstone and Dinsmore recently had a discussion with Lt. Gov. Susan Bysiewicz regarding how the Connecticut state can make efforts to enhance technical advances and start-ups.
The partners estimated that their AR device could aid in planning a surgical procedure. It can also make the patient understand what is going on with 3D demonstrations, and act as guidance during the surgery itself. Pearlstone spoke about his new augmented reality development in glowing terms. He expressed that although he has worked at different places throughout his career, he now has renewed enthusiasm for coming to work regularly.
SphereGen is also working towards raising the practicality of augmented reality. The company led by Dinsmore currently has a dozen-strong workforce at its District New Haven tech park location and a total workforce of 60 across the globe. They are combining game development with medical software. Pearlstone has been on a journey of personal growth in recent times. He went to business school, explored administrative roles and was a startup incubator director when he was approached by Dinsmore with the concepts of virtual reality (VR) in medicine. He remarked that he was overwhelmed with understanding the concept as it was quite close to what he had envisioned. Pearlstone acknowledged that Ted had realised how technology would positively impact medicine.
The meeting with Dinsmore changed Pearlstone’s perspective, who left his job soon after to become the Dicom Director’s CEO. The company had been integrated a year earlier. The two company owners are now collaborating with several prospective partners including Dartmouth College and Yale University. Pearlstone believes that a lot more is yet to come. He pointed out how dissatisfied surgeons across the world were for using systems with dated technology. Pearlstone himself wondered why the medical sector was so behind on technological innovation.
Dinsmore revealed that currently there are 10 organisations around the world working on developing this type of technology. He said that the industry is now at a very early stage, and acknowledged that the bulk of developments are yet to come. He said that Chinese operating rooms are currently using the AR hologram technology, whilst companies in the US are yet to incorporate it due to the safety-focused regulatory procedures. Pearlstone said that once the technology gets its go-ahead in the U.S. it will be picked up by medical organisations everywhere.
